Rubrik Inc. Class A Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Rubrik Inc. Class A Common Stock trades at $122.29 (market cap $25.06B), while Roivant Sciences Ltd. Common Shares trades at $35.12 (market cap $24.72B). The key difference: Rubrik Inc. Class A Common Stock and Roivant Sciences Ltd. Common Shares are close in size by market cap, and Rubrik Inc. Class A Common Stock is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rubrik Inc. Class A Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| RBRK | ROIV | |
|---|---|---|
Market Cap | $25.06B | $24.72B |
Volume | 2,394,852 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $125.80 | $41.81 |
52-Week Low | $43.81 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $24.46B | $20.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Rubrik provides data security and cyber recovery software for enterprises. Its platform protects data across on-premises, cloud, SaaS, and unstructured-data environments.
Read more on RBRK →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →